Chilblain lupus erythematosus Hutchinson: Successful treatment with mycophenolate mofetil [7]

Archives of Dermatology

Volumn 137, Issue 2, 2001, Pages 235-236

  Boehm, I ^a   Bieber, T ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; DAPSONE; HYDROXYCHLOROQUINE SULFATE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOXIFYLLINE; PREDNISONE;

AGED; AUTOIMMUNE DISEASE; CASE REPORT; CORTICOSTEROID THERAPY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; TREATMENT OUTCOME;

AGED; CHILBLAINS; FEMALE; FINGERS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYCOPHENOLIC ACID;

EID: 0035118370     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Chilblain lupus erythematosus: Report of 15 cases
2. Chilblain lupus erythematosus (Hutchinson). A clinical and laboratory study of 17 patients
3. Chilblain Lupus erythematodes
4. Chilblain lupus erythematosus of Hutchinson responding to surgical treatment: A report of two patients with anti-Ro/SSA antibodies
5. European mycophenolate mofetil cooperative study group, placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
6. Mycophenolate mofetil, a rationally designed immunosuppressive drug
7. Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil
8. 2-Morpholino-ethyl mycophenolic acid (ME-MPA) inhibits lymphocyte mitogen responses in rheumatoid arthritis
9. Mycophenolate mofetil therapy in lupus nephritis: Clinical observations